ArticleOncotarget2017

Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy.

Ernestina Marianna De Francesco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.